Introduction
Post-translational modification of C-terminal CAAX sequences by covalent attachment of isoprenyl chains is crucial for intracellular localization and proper function of small GTPases such as Ras, Rac, Rho, and CDC42 (1, 2) . The substrates for these modifications are the 15-carbon isoprenoid farnesyl pyrophosphate (FPP) or the 20-carbon isoprenoid geranyl-geranyl pyrophosphate (GGPP) synthesized by enzymes of the mevalonate pathway(3) (Fig. 1A) . A key branch point enzyme of the mevalonate pathway is Farnesyl Pyrophosphate Synthetase (FPPS), a ~30kda Mg
2+
-dependent homodimeric enzyme that synthesizes (E,E)-FPP from isopentyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP)(4,5) (Fig. 1B) .
Interest in understanding FPPS activity stems from the recent discovery that FPPS is the molecular target of N-containing bisphosphonates (6, 7) . Bisphophonates are non-cleavable pyrophosphate (P-O-P) analogs in which the central oxygen is replaced by a carbon (P-C-P) with various side chains (Fig. 1C) . Against parasitic organisms (8, 9) these agents have been shown in vitro to disrupt cell growth through FPPS inhibition. In people, bisphosphonates are targeted to bone tissue (10) where FPPS inhibition in bone-resorbing osteoclasts is a current therapeutic approach for treating postmenopausal osteoporosis (11, 12) . Because of their bone targeting properties, bisphosphonates have also found use as agents to treat tumor-induced hypercalcemia(13), Paget's disease (14) , and osteolytic metastases (15) .
Although structures of apo and ligand-bound avian FPPS have been solved (16, 17) , the active sites are unassembled and do not provide substantial information concerning catalysis.
Thus, to resolve the molecular basis of catalysis, and also to understand the structural features governing bisphosphonate recognition, we determined the structures of unliganded S. aureus FPPS (FPPS-Sa), as well as two E. coli FPPS (FPPS-Ec) ternary complexes. These ternary complexes include a 2.4Å "substrate-bound" structure containing IPP and the noncleavable DMAPP analogue dimethylallyl S-thiolodiphosphate (DMSPP) (18) , and a 1.95Å bisphosphonate-bound structure containing IPP and the osteoporosis drug 1-hydroxy-2-(3-pyridinyl)ethylidene bis-phosphonic acid (risedronate) (Fig 1C) . Since the E. coli enzyme shares conserved active site residues with human FPPS(19) these complexes provide a structural framework for the development of novel FPPS inhibitors.
Materials and Methods
Enzyme Expression and Purification -Open reading frames encoding FPPS genes were amplified using the polymerase chain reaction from E. coli (JM109) and S. aureus (ATCC35556D) genomic DNA. The resulting PCR products were cloned into an E. coli expression vectors to give an open reading frame encoding FPPS-Ec fused to N-terminal sixhistidine tag and FPPS-Sa fused to C-terminal six-histidine tag. To generate selemenomethionine-labeled protein, the expression plasmid was transformed into the methionine auxotroph DL41 (21) . Recombinant FPPS' were purified using ProBond NickelChelating resin (Invitrogen; Carlsbad, CA) followed by diafiltration into 150 mM NaCl, 25 mM Tris pH 7.9, 0.25 mM TCEP.
Crystallization and Structure Determination -Crystals of selenomethionine-labeled S. aureus FPPS were grown using nanovolume crystallization techniques by mixing 50nL of protein solution with 50nL of reservoir (22 Crystals were harvested in reservoir solutions supplemented with 20% ethylene glycol, and flash frozen by direct immersion in liquid nitrogen. X-ray diffraction data from the S. aureus crystals were collected at the Advanced Light Source (ALS) Beam Line 5.0.2 using a wavelength of 0.978Å. X-ray diffraction data from the E. coli crystals were collected at ALS Beam Line 5.0.3 using a wavelength of 1.00Å. All data were integrated and scaled using HKL2000 (23) . Crystals of the S. aureus enzyme belong to the space group P6 1 22 and have two molecules in the asymmetric unit. Ligand-bound crystals of the E .coli enzyme belong to the space group P4 1 22 and contain two molecules in the asymmetric unit. Data collection and refinement statistics are listed in table I. The structure of S. aureus FPPS was determined using SAD phases calculated with the program SHARP (24) . The E. coli structures were determined by molecular replacement using AMoRe (25) with the refined S. aureus structure (~40% sequence identity) as a search model. Both structures were refined without non-crystallographic symmetry restraints in REFMAC and inspected, built, and rebuilt using Xfit (26) . The atomic coordinates of the S. aureus (accession code -1RTR) enzyme as well as the E. coli substrate (accession code -1RQI), and risedronate (accession code -1RQJ) complexes have been deposited with the Protein Data Bank. (Fig 2A) . Compared to the unliganded S. aureus and avian structures (16, 17) , the E. coli ternary complexes reveal active-site conformational changes localized at the enzyme Cterminus and the α4-α5 and α9-α10 loops. Significantly, all three regions contain conserved residues that contact substrate and inhibitor diphosphate atoms. FPPS binds to the DMSPP diphosphate through a trinuclear Mg 2+ cluster that is ligated by three conserved aspartates located on opposite walls of the active-site cavity (Fig. 2B) The hydrocarbon tail of DMSPP extends into a deep pocket that accommodates the growing isoprenyl product (16, 17) (Fig 2B) . The pocket extends to the dimer interface with residues from helix 4 (Tyr100, Ser101, His104, and Met110), helix 7 (Met 175 and Cys176), and helix 6 (Ile132, Leu133, Asp136) of the adjacent subunit forming the walls of the pocket.
RESULTS

S. aureus FPPS -
Hydrophobic interactions with Gln179 and Lys202 on one side and Ser101, Leu102, and Thr203 on the other, position the DMSPP hydrocarbon tail within van der Waals distance of the C1, C2, C3, and C4 atoms of IPP.
IPP binding is mediated by the enzyme's C-terminus that organizes residues contacting the IPP pyrophosphate (Fig. 2B) . A salt bridge between the C-terminal carboxylate and Lys66 positions its side chain Nε atom to directly interact with two nonbridging diphosphate oxygens.
Arg318, which is also positioned by a C-terminal salt bridge, forms a water mediated interaction to a single diphosphate oxygen. Additional interactions to the IPP pyrophosphate include hydrogen bonds with Gly65 and His98, and salt bridges with Arg69 and Arg117. These enzyme:IPP pyrophosphate interactions anchor IPP in the FPPS active site such that its hydrocarbon tail is buttressed between conserved Phe240 and the hydrophobic tail of DMSPP (Fig 2B) . Notably, these interactions position the nucleophilic C3-C5 double bond of IPP 3.2Å
from the C1 atom of DMSPP (Fig 3A) . (Fig 2C) . The conformational changes, interactions with IPP, as well as the interactions to the inhibitors carbon-linked pyrophosphate, mimic those seen in the substrate complex. The pyridyl side chain of the bisphosphonate inhibitor binds to the same hydrophobic pocket that accommodates the C5-hydrocarbon tail of DMSPP. Similar stacking interactions to those described for DMSPP, as well as a hydrogen bond between the pyridyl nitrogen and conserved Thr203 position the inhibitor to make tight van der Walls contacts with IPP.
Discussion
Structure-Based Three-Metal-Ion Catalytic Mechanism -Biochemical studies have revealed that the reaction catalyzed by FPPS occurs by a three-step ionization-condensation-elimination mechanism (27) in which the double bond of IPP is stereospecifically alkylated by the C1 atom of the allylic substrate(28). The 2.4Å structure of the IPP:DMSPP ternary complex reveals the structural basis for this three-step mechanism. (Fig 2B) .
These interactions, as well as those to the IPP pyrophosphate, juxtapose the hydrophobic C5 isoprenoid tails in a conformation suitable for catalysis. Initial ionization of the allylic disphosphate triggered by the FPPS metal center would thus generate an allylic carbocation with its positive charge distributed over the C1, C2, and C3 atoms. As pyrophosphate is generated, the developing negative charge would be stabilized by interactions with the trinuclear metal center. Likewise, the positively charged allylic cation is stabilized by electrostatic interactions with the liberated pyrophosphate and also through conserved FPPS interactions. Notably, the main chain carbonyl oxygen of Lys202, and the side chain oxygens of Thr203 and Gln241, form a carbocation binding site by directing their negative dipoles toward the positive charge localized over the DMAPP C1, C2, and C3 atoms (Fig 3A,3B ). Our trapped substrate complex suggests that this cation would be quickly condensed with the nucleophilic C3-C5 double bond of IPP which is only 3.2Å from the DMSPP C1 position (Fig 3A) . Our structure further reveals that a non-metal ligated pyrophosphate oxygen is the catalytic base that deprotonates the condensed intermediate to generate the C5-extended isoprenoid reaction product. (Fig. 3A, 3B ). In the ternary complex this catalytic oxygen is ligated by conserved Arg116 and Lys258 (Fig 3A) and, consistent with biochemical data (28, 29) , is correctly positioned to abstract the IPP C2 pro-R hydrogen. Notably, both Arg116 and Lys258 emanate from the conformationally variable α4-α5
and α9-α10 active-site loops that shield the reaction from bulk solvent. Pyrophosphate-mediated proton abstraction would weaken these interactions and could thus disrupt the structure of these loops to facilitate pyrophosphate release and IPP reloading. by guest on November 17, 2017 
